跳至主要内容
临床试验/NCT06087211
NCT06087211已完成不适用

Pain Relieving Potentials of Preoperative Combination of Single Dose Oral Duloxetine and Intravenous Magnesium Sulphate in Acute and Chronic Post Mastectomy Pain: A Randomized Controlled Trial

National Cancer Institute, Egypt1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2023年10月10日最近更新:
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
90
试验地点
1
主要终点
Time to first analgesic request

研究概览

简要总结

This study aims to evaluate the effect of combined duloxetine and IV Magnesium sulphate to decrease acute and chronic post mastectomy pain.

The study will be conducted in National Cancer Institute and all the participants will be enrolled from female patients scheduled for modified radical mastectomy under general anesthesia in National Cancer Institute, Cairo University.

详细描述

It has been reported recently that Duloxetine improved the quality of recovery in patients subjected to hysterectomy. In this context, mastectomy has a negative consequence starting from cancer diagnosis to the squeal of cancer-related treatments and it has been estimated that 20%-30% of patients with breast cancer suffer from depression and anxiety. Magnesium also antagonizes the release of inflammatory mediators such as histamine, serotonin, and cytokines in peripheral tissues.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Age from 18 to 65 years old.
  • American Society of Anesthesiologists (ASA) physical I-II
  • Scheduled for modified radical mastectomy (MRM) under general anesthesia.

排除标准

  • Liver or kidney disease
  • Patient with previous chronic pain on opioids
  • Patients on antidepressants and antipsychotics.
  • Allergies to study drugs

研究组 & 干预措施

DM group

Active Comparator

Patients received Duloxetine 30mg orally and an intravenous infusion of magnesium sulphate 50mg/kg mixed with 200 ml of normal saline.

干预措施: Magnesium sulphate and Duloxetine (Drug)

D group

Active Comparator

Patients received Duloxetine 30mg orally and 200 ml of normal saline.

干预措施: Duloxetine (Drug)

Control group

Placebo Comparator

Patients received a placebo capsule and an intravenous infusion of 200 mL of normal saline

干预措施: Placebo and normal saline (Drug)

结局指标

主要结局

Time to first analgesic request

时间窗: 48 hours postoperatively

Time to the first request for the rescue analgesia (time from end of surgery to first dose of morphine administared).

次要结局

  • Total morphine consumption(48 hours postoperatively)
  • Degree of pain(48 hours postoperatively)
  • Incidence of post-mastectomy pain syndrome(12 weeks postoperatively)
  • Degree of patient satisfaction(48 hours postoperatively)
  • Incidence of adverse events(at 8 weeks postoperative and 12 weeks postoperative)

研究者

发起方
National Cancer Institute, Egypt
申办方类型
Other
责任方
Principal Investigator
主要研究者

Norma Osama Abdalla Zayed

Lecturer of Anesthesia, Surgical ICU and Pain Management, National Cancer Institute, Cairo University

National Cancer Institute, Egypt

研究点 (1)

Loading locations...

相似试验

Pain Relieving Potentials of Combination of Oral... | 临床试验